1. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
   Nicola Cirillo, 2023, International Journal of Molecular Sciences CrossRef
2. Functional analysis of CD44 variants and xCT in canine tumours
   Atsushi Tanabe et al, 2021, Veterinary Medicine and Science CrossRef
3. Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression
   Qiu‐Yun Luo et al, 2022, Cancer Science CrossRef
4. The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells
   Mario Alejandro Aguilar-Chaparro et al, 2023, Stem Cell Research CrossRef
5. RNA-binding proteins regulating the CD44 alternative splicing
   Diana Maltseva et al, 2023, Frontiers in Molecular Biosciences CrossRef
6. Prognostic value of CD44v9 expression in human cancers: Retraction
   Li Zeng et al, 2020, Medicine CrossRef
7. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
   Min Yu et al, 2019, Frontiers in Oncology CrossRef
8. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas
   Chongxian Hou et al, 2019, Journal of Neuro-Oncology CrossRef
9. CD44: A Multifunctional Mediator of Cancer Progression
   Malak Hassn Mesrati et al, 2021, Biomolecules CrossRef
10. CD44 and its implication in neoplastic diseases
    Yiming Xu et al, 2024, MedComm CrossRef
11. Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy
    Kangqi Yang et al, 2024, Frontiers in Molecular Biosciences CrossRef
12. Brain proteomic differences between wild-type and CD44- mice induced by chronic Toxoplasma gondii infection
    Jing Yang et al, 2018, Parasitology Research CrossRef
13. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
    Debanwita Roy Burman et al, 2021, Molecular Biology Reports CrossRef
14. The role of CD44 in cancer chemoresistance: A concise review
    Zohreh Yaghobi et al, 2021, European Journal of Pharmacology CrossRef
15. Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis (Review)
    Hiroshi Kobayashi et al, 2022, Oncology Letters CrossRef
16. Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors
    Chen Duan et al, 2023, Frontiers in Oncology CrossRef
17. CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
    Nattawan Suwannakul et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
18. Role of CD44 in breast cancer
    Nihad Al-Othman et al, 2020, Breast Disease CrossRef
19. CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway
    Yi-Nan Liu et al, 2024, Life Sciences CrossRef
20. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis
    Kevin Dzobo et al, 2021, OMICS: A Journal of Integrative Biology CrossRef
21. Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
    Laura M. Urbanski et al, 2018, WIREs RNA CrossRef
22. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing
    Xiaohui Hu et al, 2020, Nature Communications CrossRef
23. Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis
    Mark Primeaux et al, 2022, Clinical & Experimental Metastasis CrossRef